Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06034561
Title Bortezomib-based Regimen for Refractory or Relapsed Acute Lymphoblastic Leukemia
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Instituto do Cancer do Estado de São Paulo
Indications
Therapies
Age Groups: child | adult
Covered Countries BRA


No variant requirements are available.